Skip to content
healthcare.dev
Get a free key

TRODELVY

NDC 55135-132, SACITUZUMAB GOVITECAN, powder, for solution, from Gilead Sciences, Inc..

Product NDC
55135-132
Status
Listed
Labeler
Gilead Sciences, Inc.
Dosage form
POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761115
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55135-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SACITUZUMAB GOVITECAN180 mg/1
Package NDCNDC-11Package
55135-132-01551350132011 VIAL in 1 BOX (55135-132-01) / 1 POWDER, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/57a597d2-03f0-472e-b148-016d7169169d

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55135-132

Use it

Look up 55135-132 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55135-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55135-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.